AbbVie Inc (NYSE:ABBV)
| 60.35 Data as of Jan 30 |  -2.77 / -4.39%Today’s Change | 45.50 Today|||52-Week Range 70.76 | -7.78% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Operating Activities | Net Income / Starting Line | 4.2B | 3.4B | 5.3B | 4.1B | |
| Depreciation | 1.2B | 1.3B | 1.2B | 897.0M | ||
| Total Other Cash Flow | 313.2M | 672.5M | 541.0M | 584.0M | ||
| Funds From Operations | 5.8B | 5.5B | 7.0B | 5.6B | ||
| Funds From/For Other Operating Expenses | 866.0M | -706.2M | 621.0M | -658.0M | ||
| Net Cash Flow - Operating Activities | 5.0B | 6.2B | 6.3B | 6.3B | ||
| Investing | Increase In Investments | -93.6M | -1.9B | -2.6B | -930.0M | |
| Decrease In Investments | 939.0K | 1.3B | 1.2B | 2.7B | ||
| Capital Expenditures | -448.1M | -355.5M | -333.0M | -491.0M | ||
| Net Assets From Acquisitions | -2.6B | -272.5M | -688.0M | -405.0M | ||
| Other Investing - Uses | -1.9B | 0.00 | 0.00 | 0.00 | ||
| Other Investing - Sources | 378.0K | 1.9B | 0.00 | 0.00 | ||
| Net Cash Flow Investing | -5.0B | 553.9M | -2.4B | 879.0M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 1.0B | -601.0M | |
| Long Term Borrowings | 0.00 | 0.00 | 14.6B | 0.00 | ||
| Long Term Debt Reduction | -32.1M | -21.1M | 0.00 | 0.00 | ||
| Net Proceeds Stock Sale | 0.00 | 0.00 | 0.00 | 347.0M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | -320.0M | ||
| Common Dividends | 0.00 | 0.00 | 0.00 | -2.6B | ||
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | -2.6B | ||
| Other Sources - Financing | 97.3M | 0.00 | 0.00 | 0.00 | ||
| Other Uses - Financing | -- | 6.8B | 13.7B | 313.0M | ||
| Net Cash Flow - Financing | 65.2M | -6.8B | 1.9B | -3.4B | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | 16.0M | -10.0M | |
| Net Change In Cash | 9.6M | 17.8M | 5.9B | 3.7B | ||
.